United States · FDA National Drug Code directory
Megestrol Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70954-896_a26dcd78-ad62-4cf5-ad97-49ccb34d43ba
- Product NDC
- 70954-896
- Form
- SUSPENSION
- Composition / generic term
- Megestrol Acetate
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240702
- Source listing expiry
- 20261231
Source-listed ingredients
- MEGESTROL ACETATE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 240 mL in 1 BOTTLE (70954-896-10) · 70954-896-10
- 480 mL in 1 BOTTLE (70954-896-20) · 70954-896-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →